62
Views
0
CrossRef citations to date
0
Altmetric
Research Communications

LncRNA PSMG3-AS1 is upregulated in prostate carcinoma and downregulates miR-106b through DNA methylation

, , &
Pages 264-270 | Received 28 Jul 2022, Accepted 28 Feb 2023, Published online: 06 Apr 2023

References

  • Bleyer A, Spreafico F, Barr R. 2020. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 126(1):46–57.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Cai K, Wang Y, Bao X. 2011. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. J Exp Clin Cancer Res. 30(1):73.
  • Chen L, Wang G, Xu Z, Lin K, Mu S, Pan Y, Shan M. 2020. Overexpression of LncRNA PSMG3-AS1 distinguishes glioblastomas from sarcoidosis. J Mol Neurosci. 70(12):2015–2019.
  • Cui Y, Fan Y, Zhao G, Zhang Q, Bao Y, Cui Y, Ye Z, Chen G, Piao X, Guo F, et al. 2020. Novel lncRNA PSMG3AS1 functions as a miR1433p sponge to increase the proliferation and migration of breast cancer cells. Oncol Rep. 43(1):229–239.
  • Halabi S, Small EJ, Kantoff PW, Kattan MW, Kaplan EB, Dawson NA, Levine EG, Blumenstein BA, Vogelzang NJ. 2003. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 21(7):1232–1237.
  • Li W, Yang G, Yang D, Li D, Sun Q. 2020. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/beta-catenin pathway. Cancer Cell Int. 20(1):543.
  • Liu HT, Fang L, Cheng YX, Sun Q. 2016. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. Cancer Med. 5(12):3512–3519.
  • Meng Q, Liang C, Hua J, Zhang B, Liu J, Zhang Y, Wei M, Yu X, Xu J, Shi S. 2020. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 10(9):3967–3979.
  • Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X, Ding Q, Zha X, Sha J, Wang S. 2014. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2. Cancer Sci. 105(1):18–25.
  • Rusthoven CG, Jones BL, Flaig TW, Crawford ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD, et al. 2016. Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer. J Clin Oncol. 34(24):2835–2842.
  • Shen G, Jia H, Tai Q, Li Y, Chen D. 2013. miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Carcinogenesis. 34(1):211–219.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34.
  • Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. 2021. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 41(2):109–120.
  • Wang W, Zhu Y, Li S, Chen X, Jiang G, Shen Z, Qiao Y, Wang L, Zheng P, Zhang Y. 2016. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting beta-catenin via Ezh2. Oncotarget. 7(18):25668–25682.
  • Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Clarke NW, Collette L, Dignam JJ, et al. 2017. Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer. J Clin Oncol. 35(27):3097–3104.
  • Xue D, Zhou C, Lu H, Xu R, Xu X, He X. 2016. LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway. Tumor Biol. 37(12):16187–16197.
  • Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. 2016. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 22(22):5183–5192.
  • Yu Y, Lu X, Yan Y, Wang Y, Meng J, Tian S, Mu J. 2022. The lncRNA KIF9-AS1 accelerates hepatocellular carcinoma growth by recruiting DNMT1 to promote RAI2 DNA methylation. J Oncol. 2022:3888798.
  • Yue N, Ye M, Zhang R, Guo Y. 2020. MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma. BMC Pulm Med. 20(1):152.
  • Zhang J, Huang J, Chen W, Hu Z, Wang X. 2020. miR-143-3p targets lncRNA PSMG3-AS1 to inhibit the proliferation of hepatocellular carcinoma cells. Cancer Manag Res. 12:6303–6309.
  • Zhang J, Liu H, Zhao P, Zhou H, Mao T. 2019. Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p. J Cell Biochem. 120(3):3027–3037.
  • Zheng L, Zhang Y, Lin S, Sun A, Chen R, Ding Y, Ding Y. 2015. Down-regulation of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer. Int J Clin Exp Pathol. 8(9):10534–10544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.